Modulation of outer membrane vesicle-based immune responses by cathelicidins

Area of Science:

• Immunology
• Microbiology
• Vaccine Development

Background:

• Antibiotic resistance necessitates novel vaccine strategies, with bacterial outer membrane vesicles (OMVs) showing promise for Gram-negative bacteria.
• Lipopolysaccharide (LPS) in OMVs can trigger unwanted immune responses via toll-like receptor 4 (TLR4) activation.
• Host defense peptides (HDPs), such as cathelicidins, are known to neutralize LPS and dampen TLR4 activation.

Purpose of the Study:

• To investigate the immune-modulating capacity of HDPs in the context of OMV-based vaccine development.
• To determine if HDPs can neutralize LPS-induced TLR4 activation when delivered via OMVs.
• To explore the differential effects of HDPs on spontaneous versus heat-induced OMVs.

Main Methods:

• Macrophage stimulation assays using spontaneous and heat-induced *B. bronchiseptica* OMVs.
• Assessment of immune modulation by cathelicidins (LL-37, CATH-2, PMAP-36, K9CATH).
• Interaction studies between cathelicidins and OMVs, and TLR screening (TLR2, 4, 5, 9).

Main Results:

• Cathelicidins LL-37, CATH-2, PMAP-36, and K9CATH modulated immune responses to OMVs.
• Immune modulation differed between spontaneous and heat-induced OMVs, with distinct cathelicidin binding modes observed.
• TLR4-mediated activation was the primary pathway for OMV-induced macrophage stimulation, though TLR2, 5, and 9 were also involved. OMV uptake was not a major factor.

Conclusions:

• HDPs, particularly cathelicidins, can modulate immune responses elicited by bacterial OMVs.
• The effectiveness of HDPs is dependent on the OMV type (spontaneous vs. heat-induced) and their interaction dynamics.
• This study provides insights into OMV-macrophage activation pathways and potential strategies for immune response modulation in OMV-based vaccines.